Clark Capital Management Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,332
Closed -$1.28M 407
2024
Q2
$1.28M Sell
11,332
-5,155
-31% -$652K 0.01% 265
2024
Q1
$2.29M Buy
16,487
+5,445
+49% +$684K 0.02% 234
2023
Q4
$1.37M Buy
+11,042
New +$1.13M 0.01% 257

Other funds holding DXCM

Clark Capital Management Group's DXCM Position: Q3 2024 in Review

Clark Capital Management Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 11,332 shares — an estimated $1.28M sold.

Clark Capital Management Group first reported a position in DXCM in Q4 2023 and held it in 3 quarters. The position peaked at $2.29M in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Clark Capital Management Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Clark Capital Management Group sold 11,332 DexCom shares in Q3 2024, an estimated $1.28M.
  • Clark Capital Management Group first reported a position in DexCom in Q4 2023 and held it in 3 quarters.
  • Clark Capital Management Group's DexCom position peaked at $2.29M in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Clark Capital Management Group's 13F filing for Q3 2024, filed 14 Nov 2024.